亲爱的研友该休息了!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!身体可是革命的本钱,早点休息,好梦!

Abbreviated Antiplatelet Therapy After Coronary Stenting in Patients With Myocardial Infarction at High Bleeding Risk

医学 心肌梗塞 内科学 急性冠脉综合征 心脏病学 不利影响 人口 经皮冠状动脉介入治疗 随机化 随机对照试验 环境卫生
作者
Pieter C. Smits,Enrico Frigoli,Pascal Vranckx,Yukio Ozaki,Marie‐Claude Morice,Bernard Chevalier,Yoshinobu Onuma,Stephan Windecker,Pim A.L. Tonino,Marco Roffi,Maciej Lesiak,Felix Mahfoud,Jozef Bartúnek,David Hildick‐Smith,Antonio Colombo,Goran Stanković,Andrés Íñiguez,Carl Schultz,Ran Kornowski,Paul Jau Lueng Ong,Mirvat Alasnag,Alfredo E. Rodríguez,Valeria Paradies,Petr Kala,Saško Kedev,Amar Al Mafragi,Willem Dewilde,Dik Heg,Marco Valgimigli
出处
期刊:Journal of the American College of Cardiology [Elsevier BV]
卷期号:80 (13): 1220-1237 被引量:20
标识
DOI:10.1016/j.jacc.2022.07.016
摘要

The optimal duration of antiplatelet therapy (APT) after coronary stenting in patients at high bleeding risk (HBR) presenting with an acute coronary syndrome remains unclear.The objective of this study was to investigate the safety and efficacy of an abbreviated APT regimen after coronary stenting in an HBR population presenting with acute or recent myocardial infarction.In the MASTER DAPT trial, 4,579 patients at HBR were randomized after 1 month of dual APT (DAPT) to abbreviated (DAPT stopped and 11 months single APT or 5 months in patients with oral anticoagulants) or nonabbreviated APT (DAPT for minimum 3 months) strategies. Randomization was stratified by acute or recent myocardial infarction at index procedure. Coprimary outcomes at 335 days after randomization were net adverse clinical outcomes events (NACE); major adverse cardiac and cerebral events (MACCE); and type 2, 3, or 5 Bleeding Academic Research Consortium bleeding.NACE and MACCE did not differ with abbreviated vs nonabbreviated APT regimens in patients with an acute or recent myocardial infarction (n = 1,780; HR: 0.83; 95% CI: 0.61-1.12 and HR: 0.86; 95% CI: 0.62-1.19, respectively) or without an acute or recent myocardial infarction (n = 2,799; HR: 1.03; 95% CI: 0.77-1.38 and HR: 1.13; 95% CI: 0.80-1.59; Pinteraction = 0.31 and 0.25, respectively). Bleeding Academic Research Consortium 2, 3, or 5 bleeding was significantly reduced in patients with or without an acute or recent myocardial infarction (HR: 0.65; 95% CI: 0.46-0.91 and HR: 0.71; 95% CI: 0.54-0.92; Pinteraction = 0.72) with abbreviated APT.A 1-month DAPT strategy in patients with HBR presenting with an acute or recent myocardial infarction results in similar NACE and MACCE rates and reduces bleedings compared with a nonabbreviated DAPT strategy. (Management of High Bleeding Risk Patients Post Bioresorbable Polymer Coated Stent Implantation With an Abbreviated Versus Prolonged DAPT Regimen [MASTER DAPT]; NCT03023020).
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
Hello应助hsr_eye采纳,获得10
1秒前
123发布了新的文献求助10
18秒前
linshunan完成签到 ,获得积分10
23秒前
就叫希望吧完成签到 ,获得积分10
24秒前
mhq完成签到 ,获得积分20
28秒前
量子星尘发布了新的文献求助10
47秒前
57秒前
吴嘉俊完成签到 ,获得积分10
58秒前
Joeswith完成签到,获得积分10
59秒前
杨怂怂完成签到 ,获得积分10
1分钟前
风雨中飘摇应助科研通管家采纳,获得200
1分钟前
1分钟前
Chris完成签到 ,获得积分0
1分钟前
zoe完成签到 ,获得积分10
1分钟前
1分钟前
1分钟前
大个应助CNS_Fighter88采纳,获得10
1分钟前
轻松的惜芹完成签到,获得积分10
1分钟前
howgoods完成签到 ,获得积分10
1分钟前
1分钟前
Kashing完成签到,获得积分10
1分钟前
CNS_Fighter88发布了新的文献求助10
2分钟前
2分钟前
l123完成签到,获得积分10
2分钟前
CYC完成签到 ,获得积分10
2分钟前
zhao完成签到 ,获得积分10
2分钟前
脑洞疼应助l123采纳,获得10
2分钟前
大个应助守仁则阳明采纳,获得10
2分钟前
2分钟前
木有完成签到 ,获得积分10
2分钟前
2分钟前
科研通AI5应助10 g采纳,获得10
2分钟前
Zoe发布了新的文献求助30
2分钟前
2分钟前
Zoe完成签到,获得积分10
2分钟前
糖伯虎完成签到 ,获得积分10
2分钟前
量子星尘发布了新的文献求助10
2分钟前
2分钟前
l123发布了新的文献求助10
2分钟前
wys完成签到,获得积分10
2分钟前
高分求助中
A new approach to the extrapolation of accelerated life test data 1000
Picture Books with Same-sex Parented Families: Unintentional Censorship 700
ACSM’s Guidelines for Exercise Testing and Prescription, 12th edition 500
Nucleophilic substitution in azasydnone-modified dinitroanisoles 500
不知道标题是什么 500
Indomethacinのヒトにおける経皮吸収 400
Phylogenetic study of the order Polydesmida (Myriapoda: Diplopoda) 370
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 冶金 细胞生物学 免疫学
热门帖子
关注 科研通微信公众号,转发送积分 3976608
求助须知:如何正确求助?哪些是违规求助? 3520700
关于积分的说明 11204542
捐赠科研通 3257350
什么是DOI,文献DOI怎么找? 1798716
邀请新用户注册赠送积分活动 877881
科研通“疑难数据库(出版商)”最低求助积分说明 806613